MLG Oz Limited
MLG Oz Limited (MLG.AX) Financial Performance & Income Statement Overview
Explore the financials of MLG Oz Limited (MLG.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
MLG Oz Limited (MLG.AX) Income Statement & Financial Overview
Review MLG Oz Limited MLG.AX income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $136.43M | $136.43M | $245.40M | $124.24M |
| Cost of Revenue | $92.13M | $92.13M | $150.91M | $83.21M |
| Gross Profit | $44.30M | $44.30M | $94.48M | $41.04M |
| Gross Profit Ratio | $0.32 | $0.32 | $0.39 | $0.33 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $27.91M | $27.91M | $89.73M | $26.16M |
| Operating Expenses | $27.91M | $27.91M | $86.63M | $26.16M |
| Total Costs & Expenses | $120.05M | $120.05M | $237.55M | $109.36M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $1.88M | $0.00 |
| Depreciation & Amortization | $9.72M | $9.72M | $18.92M | $7.79M |
| EBITDA | $14.65M | $14.65M | $26.59M | $11.71M |
| EBITDA Ratio | $0.11 | $0.11 | $0.11 | $0.09 |
| Operating Income | $16.39M | $16.39M | $7.85M | $14.88M |
| Operating Income Ratio | $0.12 | $0.12 | $0.03 | $0.12 |
| Other Income/Expenses (Net) | -$13.26M | -$13.26M | -$2.06M | -$11.99M |
| Income Before Tax | $3.12M | $3.12M | $5.79M | $2.89M |
| Income Before Tax Ratio | $0.02 | $0.02 | $0.02 | $0.02 |
| Income Tax Expense | $1.08M | $1.08M | $1.95M | $977279.00 |
| Net Income | $2.04M | $2.04M | $3.83M | $1.92M |
| Net Income Ratio | $0.01 | $0.01 | $0.02 | $0.02 |
| EPS | $0.01 | $0.01 | $0.03 | $0.01 |
| Diluted EPS | $0.01 | $0.01 | $0.02 | $0.01 |
| Weighted Avg Shares Outstanding | $147.62M | $147.62M | $146.79M | $181.34M |
| Weighted Avg Shares Outstanding (Diluted) | $163.28M | $163.28M | $162.20M | $182.67M |
Over the last four quarters, MLG Oz Limited achieved steady financial progress, growing revenue from $124.24M in Q3 2024 to $136.43M in Q2 2025. Gross profit stayed firm with margins at 32% in Q2 2025 versus 33% in Q3 2024. Operating income totaled $16.39M in Q2 2025, maintaining a 12% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $14.65M. Net income rose to $2.04M, with EPS at $0.01. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan